Tips on using this search form
- All search terms are case-insensitive
- If you specify more than one search option (e.g. you search for both "Authors" and "Paper title") then the publications returned will be those that match all of your search terms
- To reset the search form, click here
- Currently displaying 61 - 80 of 2469 publications
A Cathepsin B‐Triggered CO‐Releasing Molecule with a Non‐Toxic Metal Core for Targeted Tumor Delivery
Angewandte Chemie
(2025)
138
e13808
(doi: 10.1002/ange.202513808)
Identification of potent high-affinity secondary nucleation inhibitors of Aβ42 aggregation from an ultra-large chemical library using Deep Docking
Mol Syst Biol
(2025)
22
69
(doi: 10.1038/S44320-025-00159-5)
PhaseXplorer Creates High-Dimensional Phase Diagrams with Closed-Loop Active Learning
ACS nano
(2025)
19
38981
(doi: 10.1021/acsnano.5c07268)
Deep learning assessment of nativeness and pairing likelihood for antibody and nanobody design with AbNatiV2
(2025)
(doi: 10.1101/2025.10.31.685806)
Neurodegeneration emerges at a cellular tipping point between aggregate accumulation and removal.
(2025)
(doi: 10.1101/2025.09.08.674880)
Kinetics of seeded protein aggregation: theory and application
(2025)
(doi: 10.48550/arxiv.2503.20941)
Droplet-based microfluidics uncovers hidden kinetic pathways of protein condensates: divergent routes to amyloids and amorphous aggregates.
(2025)
A Mathematical Model of Cellular Aggregation Predicts Patterns of Tau Accumulation in Neurodegenerative Disease.
Adv Sci (Weinh)
(2025)
13
e11297
(doi: 10.1002/advs.202511297)
BLOSUM Is All You Learn Generative Antibody Models Reflect Evolutionary Priors
(2025)
(doi: 10.1101/2025.10.26.684652)
Tau catalyzes amyloid-β aggregation in a fold-dependent manner
(2025)
(doi: 10.1101/2025.10.21.683640)
α-Synuclein driven cell susceptibility in Parkinson’s disease
(2025)
(doi: 10.21203/rs.3.rs-7375981/v1)
YTHDC1 inhibition as a therapeutic strategy with potent preclinical activity alone and in combination with BCL-2 inhibitors
Molecular Cancer Therapeutics
(2025)
24
B124
Disease-disease interactions: molecular links of neurodegenerative diseases with cancer, viral infections, and type 2 diabetes.
Translational neurodegeneration
(2025)
14
52
(doi: 10.1186/s40035-025-00507-3)
Size of biomolecular condensates dictates fate in liquid–solid phase transitions through amorphous–amyloid competition
(2025)
(doi: 10.26434/chemrxiv-2025-6xwcg)
Large-scale visualisation of α-synuclein oligomers in Parkinson’s disease brain tissue
Nat Biomed Eng
(2025)
1
(doi: 10.1038/s41551-025-01496-4)
Serial amplification of tau filaments using Alzheimer's brain homogenates and C322A or C322S recombinant tau.
FEBS Letters
(2025)
599
2768
(doi: 10.1002/1873-3468.70141)
Nanoscale profiling of evolving intermolecular interactions in ageing FUS condensates
Communications Chemistry
(2025)
8
284
(doi: 10.1038/S42004-025-01659-Z)
Advances in Proximity-Assisted Bioconjugation
Accounts of Chemical Research
(2025)
58
2939
(doi: 10.1021/acs.accounts.5c00368)
Optofluidic waveguides for the label-free study of silk protein aggregates
ACS Omega
(2025)
10
46115
(doi: 10.1021/acsomega.5c07826)